IVHD-valtrate
| Code | Size | Price |
|---|
| TAR-TN4341-10mg | 10mg | £2,479.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeutic agent for ovarian cancer, providing a basis for development of the compound as a novel chemotherapeutic agent.
CAS:
28325-56-6
Formula:
C27H40O11
Molecular Weight:
540.6
Pathway:
Apoptosis; Proteases/Proteasome; Chromatin/Epigenetic; DNA Damage/DNA Repair
Purity:
0.98
SMILES:
CC(C)CC(=O)OC(C(C)C)C(=O)OCC1=CO[C@@H](OC(=O)CC(C)C)C2[C@]3(CO3)[C@H](C[C@]12O)OC(C)=O
Target:
Mdm2; BCL; PARP; Caspase; p53